title: The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II.
abstract: Inactivation of the HRPT2 tumor suppressor gene is associated with the pathogenesis of the hereditary hyperparathyroidism-jaw tumor syndrome and malignancy in sporadic parathyroid tumors. The cellular function of the HPRT2 gene product, parafibromin, has not been defined yet. Here we show that parafibromin physically interacts with human orthologs of yeast Paf1 complex components, including PAF1, LEO1, and CTR9, that are involved in transcription elongation and 3' end processing. It also associates with modified forms of the large subunit of RNA polymerase II, in particular those phosphorylated on serine 5 or 2 within the carboxy-terminal domain, that are important for the coordinate recruitment of transcription elongation and RNA processing machineries during the transcription cycle. These interactions depend on a C-terminal domain of parafibromin, which is deleted in ca. 80% of clinically relevant mutations. Finally, RNAi-induced downregulation of parafibromin promotes entry into S phase, implying a role for parafibromin as an inhibitor of cell cycle progression. Taken together, these findings link the tumor suppressor parafibromin to the transcription elongation and RNA processing pathway as a PAF1 complex- and RNA polymerase II-bound protein. Dysfunction of this pathway may be a general phenomenon in the majority of cases of hereditary parathyroid cancer.
authors.affiliation: Institute of Cell Biology, ETH Hönggerberg, CH-8093 Zurich, Switzerland.
authors.forename: Armelle
authors.initials: A
authors.lastname: Yart
authors.forename: Matthias
authors.initials: M
authors.lastname: Gstaiger
authors.forename: Christiane
authors.initials: C
authors.lastname: Wirbelauer
authors.forename: Maria
authors.initials: M
authors.lastname: Pecnik
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Anastasiou
authors.forename: Daniel
authors.initials: D
authors.lastname: Hess
authors.forename: Wilhelm
authors.initials: W
authors.lastname: Krek
mesh_terms: D000818:Animals; D002453:Cell Cycle / Q000502:physiology; D002460:Cell Line; D005786:Gene Expression Regulation; D006801:Humans; D006961:Hyperparathyroidism / Q000235:genetics / Q000378:metabolism; D018832:Molecular Chaperones / Q000235:genetics / Q000378:metabolism; D046912:Multiprotein Complexes; D009687:Nuclear Proteins / Q000235:genetics / Q000378:metabolism*; D020033:Protein Isoforms / Q000235:genetics / Q000378:metabolism*; D034622:RNA Interference; D012319:RNA Polymerase II / Q000235:genetics / Q000378:metabolism*; D029701:Saccharomyces cerevisiae Proteins / Q000235:genetics / Q000378:metabolism; D014157:Transcription Factors; D025521:Tumor Suppressor Proteins / Q000235:genetics / Q000378:metabolism*
chemical_list: C454900:CDC73 protein, human; D018832:Molecular Chaperones; D046912:Multiprotein Complexes; D009687:Nuclear Proteins; C097698:PAF1 protein, S cerevisiae; C501972:PAF1 protein, human; D020033:Protein Isoforms; D029701:Saccharomyces cerevisiae Proteins; D014157:Transcription Factors; D025521:Tumor Suppressor Proteins; D012319:RNA Polymerase II